STOCK TITAN

UBS ETRACS Alerian MLP ETN Series B SEC Filings

AMUB NYSE

Welcome to our dedicated page for UBS ETRACS Alerian MLP ETN Series B SEC filings (Ticker: AMUB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

The ETRACS Alerian MLP Index ETN Series B due July 18, 2042 (AMUB) is issued by UBS AG, a foreign private issuer that reports to the US Securities and Exchange Commission. UBS AG indicates that it files a registration statement on Form F-3, including a prospectus and supplements, for offerings of securities related to ETRACS ETNs such as AMUB. These documents set out the terms of the ETN and include a "Risk Factors" section that UBS urges investors to review before investing.

UBS AG also submits annual reports on Form 20-F and periodic reports on Form 6-K. In its Form 6-K filings, UBS provides information on capitalization, total debt issued, equity and other capital and liquidity metrics, as well as updates on regulatory developments and other corporate matters. UBS AG notes that its consolidated financial statements are prepared in accordance with IFRS Accounting Standards, and that certain 6-K reports are incorporated by reference into its Form F-3 registration statement.

For AMUB, the relevant SEC filings include the base prospectus, prospectus supplements and any pricing supplements that describe the specific terms of the ETRACS Alerian MLP Index ETN Series B. UBS’s public materials state that these offering documents are available through the SEC’s EDGAR system. They also clarify that the securities related to the offerings are not deposit liabilities and are not insured or guaranteed by the Federal Deposit Insurance Corporation or any other governmental agency of the United States, Switzerland or any other jurisdiction.

On this page, users can access AMUB-related SEC filings and associated issuer reports. The platform provides real-time updates from EDGAR and AI-powered summaries that explain the key points of lengthy documents, such as registration statements, prospectus supplements and UBS AG’s periodic reports. This allows investors to quickly identify disclosures that affect AMUB, including risk factor updates, capital and funding information, and other details relevant to UBS AG’s role as issuer of this senior unsecured ETN.

Rhea-AI Summary

UBS AG is offering Trigger Autocallable Contingent Yield Notes linked to the common stock of UnitedHealth Group Incorporated, maturing on or about February 22, 2027. Each Note has a $10 principal amount, with a minimum investment of 100 Notes ($1,000).

Investors receive a contingent coupon on each observation date only if the underlying stock closes at or above a specified coupon barrier; otherwise no coupon is paid for that period. The Notes are automatically called early if the stock closes at or above its initial level on any observation date before maturity, returning principal plus the applicable contingent coupon, with no further payments.

If the Notes are not called and the final stock level is at or above the downside threshold, investors receive back only the principal at maturity. If the final level is below that threshold, repayment of principal is reduced in line with the negative stock return, and investors can lose their entire investment. Any payment depends on the creditworthiness of UBS, the Notes will not be listed on an exchange, and the estimated initial value is expected to be between $9.48 and $9.73 per $10 Note.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

UBS AG is offering Trigger Autocallable Contingent Yield Notes linked to the common stock of Intel Corporation, maturing on or about November 20, 2028. These unsecured debt obligations pay a contingent coupon only if Intel’s closing share price on an observation date is at or above a preset coupon barrier; otherwise no coupon is paid for that period.

The Notes are automatically called if, on any monthly observation date starting after three months, Intel’s share price is at or above the initial level, in which case investors receive the principal plus any due contingent coupon and the Notes terminate. If the Notes are not called and Intel’s final share price is at or above the downside threshold at maturity, investors receive their full principal back, plus a final contingent coupon if the coupon barrier is also met.

If the Notes are not called and Intel’s final share price is below the downside threshold, repayment is reduced dollar-for-dollar with Intel’s decline, and investors can lose some or all of their initial investment. All payments, including any contingent coupons and principal repayment, depend on the creditworthiness of UBS. The Notes are offered in minimum denominations of 100 Notes at $10 each, and the estimated initial value is expected to be between $9.48 and $9.73 per Note.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

UBS AG is offering unsecured Trigger Autocallable Contingent Yield Notes linked to the common stock of UnitedHealth Group Incorporated, maturing on or about November 20, 2028. The Notes pay a contingent coupon only if the stock closes at or above a preset coupon barrier on each observation date; if it is below the barrier, no coupon is paid for that period.

The Notes are automatically called early if, on any quarterly observation date beginning after 6 months, the stock closes at or above its initial level. In that case, investors receive the principal amount plus any due contingent coupon, and the Notes terminate. If the Notes are not called and the final stock level is at or above a downside threshold, investors receive only the principal at maturity; if it is below the threshold, repayment is reduced in line with the stock’s decline, and the entire investment can be lost.

Each Note has a $10 denomination with a minimum investment of 100 Notes, and the estimated initial value per Note on the trade date is expected to be between $9.39 and $9.64. Payments depend entirely on the creditworthiness of UBS, the Notes are not insured by any government agency, and they will not be listed on any securities exchange.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
Filing
Rhea-AI Summary

UBS AG is offering Trigger Autocallable Contingent Yield Notes linked to the common stock of Advanced Micro Devices, Inc., maturing on November 20, 2028. Each Note has a principal amount of $10 and pays a contingent coupon on scheduled dates only if AMD’s stock closes at or above a preset coupon barrier on the relevant observation date.

The Notes are automatically called early if AMD’s stock closes at or above the initial level on a quarterly observation date after an initial period, in which case investors receive principal plus any due contingent coupon, and the Notes terminate. If the Notes are not called and AMD’s final stock level is at or above the downside threshold, investors receive full principal at maturity; if it is below, repayment is reduced in line with AMD’s decline and can fall to zero.

Any payment on the Notes depends on UBS’s ability to meet its obligations. The estimated initial value is $9.67 per $10 Note, and the Notes are not listed on any exchange, so liquidity may be limited.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

UBS AG is offering $140,000 of Trigger Autocallable Contingent Yield Notes linked to the common stock of Applied Materials, Inc., maturing on November 22, 2027. These are unsecured, unsubordinated debt obligations of UBS.

Investors receive a contingent coupon only on dates when the Applied Materials share price is at or above a preset coupon barrier; if it is below that level, no coupon is paid for that period. The notes are automatically called early if the stock closes at or above its initial level on any observation date before maturity, in which case UBS repays the principal plus any due coupon and the notes terminate.

If the notes are not called and the stock is at or above a downside threshold at maturity, UBS repays the full principal. If the stock is below that threshold, repayment is reduced in line with the stock’s percentage decline, and all principal can be lost. Any payment depends on UBS’s credit. The notes are not listed, have a minimum investment of 100 notes at $10 each, and an estimated initial value of $9.73 per $10 note.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

UBS AG is offering $368,000 of Trigger Autocallable Contingent Yield Notes linked to the common stock of NVIDIA Corporation, maturing on November 22, 2027. Each Note has a $10 principal amount, with a minimum investment of 100 Notes.

Investors receive a contingent coupon on each observation date only if NVIDIA’s closing level is at or above a specified coupon barrier; otherwise no coupon is paid for that period. The Notes are automatically called early if NVIDIA’s level on any observation date before maturity is at or above the initial level, in which case investors receive principal plus any due coupon and no further payments.

If the Notes are not called and NVIDIA’s final level on the November 18, 2027 final valuation date is at or above a downside threshold, investors receive full principal at maturity; if it is below that threshold, repayment is reduced in line with the stock’s percentage decline and could fall to zero. All payments depend on UBS’s credit, and the estimated initial value is $9.81 per $10 Note.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
Rhea-AI Summary

UBS AG is offering $180,000 of Trigger Autocallable Contingent Yield Notes linked to Intel Corporation common stock, maturing on November 22, 2027. These $10-denomination notes can pay periodic contingent coupons only when Intel’s stock closes at or above a specified coupon barrier on each observation date.

The notes are automatically called early if Intel’s stock closes at or above the initial level on any observation date before maturity, in which case investors receive the $10 principal plus any due coupon and no further payments. If the notes are not called and Intel’s final stock level is at or above the downside threshold, investors receive full principal at maturity, with any final coupon if the barrier is met.

If the notes are not called and Intel’s final level is below the downside threshold, the maturity payment is reduced in line with the stock’s percentage decline, and investors can lose all of their initial investment. All payments, including any repayment of principal, depend on the creditworthiness of UBS. The estimated initial value is $9.78 per $10 note.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

UBS AG is offering $300,000 of Trigger Autocallable Contingent Yield Notes linked to the common stock of United Airlines Holdings, Inc., maturing on November 22, 2027. The Notes pay a contingent coupon only on observation dates when United Airlines’ share price closes at or above a preset coupon barrier; otherwise no coupon is paid for that period.

The Notes are automatically called early if the stock closes at or above its initial level on any observation date before maturity, in which case holders receive the $10 principal per Note plus any due coupon and no further payments. If the Notes are not called and the final stock level is at or above a downside threshold, principal is repaid at maturity. If the final level is below that threshold, repayment is reduced in line with the stock’s decline, and the entire investment can be lost.

Any payment depends on the creditworthiness of UBS AG. The Notes are not listed, require a minimum investment of 100 Notes ($1,000), and have an estimated initial value of $9.77 per $10 Note.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

UBS AG, through its London branch, is offering Trigger Callable Yield Notes that pay a fixed 13.90% per annum coupon, linked to the least performing of the Nasdaq-100 Index®, Russell 2000® Index and EURO STOXX 50® Index. The notes run for about 12 months and can be called monthly by UBS after three months; if called, investors receive the $1,000 principal plus the coupon due on the call date, with no further payments.

If the notes are not called and no trigger event occurs—meaning none of the indices closes below 70% of its initial level on any day in the observation period—investors receive full principal at maturity plus the final coupon. If a trigger occurs and any index finishes below its initial level, principal is reduced in line with the percentage loss of the worst-performing index, up to a total loss of the $1,000 principal. The notes are unsecured obligations of UBS, are not FDIC-insured, will not be listed on an exchange, and have an estimated initial value of $946.60 to $976.60 per $1,000 issue price.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
Rhea-AI Summary

UBS AG is offering $250,000 of Trigger Autocallable Contingent Yield Notes linked to the Solactive U.S. Large Cap Volatility Navigator Index, maturing on November 19, 2031. Each $1,000 Note pays a contingent coupon at a 17.00% per annum rate (about $14.1667 per month) only if the index closes at or above the 70.00% coupon barrier of the 271.26 initial level on the relevant observation date.

The Notes are automatically called monthly after six months if the index is at or above the 100.00% call threshold, returning principal plus the due coupon. If not called, investors receive full principal at maturity only if the final index level is at or above the 50.00% downside threshold; below that, repayment is reduced in line with the index loss and can fall to zero.

The Notes are unsecured, unsubordinated obligations of UBS, carry UBS credit risk, will not be listed on an exchange, and have an estimated initial value of $957.50 per Note, below the $1,000 issue price due to fees, hedging and funding costs.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus

FAQ

What is the current stock price of UBS ETRACS Alerian MLP ETN Series B (AMUB)?

The current stock price of UBS ETRACS Alerian MLP ETN Series B (AMUB) is $19.2877 as of January 11, 2026.
UBS ETRACS Alerian MLP ETN Series B

NYSE:AMUB

AMUB Rankings

AMUB Stock Data

2.60M

AMUB RSS Feed